Should the Front Office-Back Office Divide End? 
Durabook Introduces the R12 Rugged Tablet Active Edge AI Platform 
IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers Rent Reporting Legislation Leads to 3,000 New Credit Scores Established in California
New data showcases how rent reporting legislation is bridging the racial wealth gap HARLEM, N.Y.,…
Spryker Recognized as a Visionary in 2023 Magic Quadrant™ for Digital Commerce
BERLIN and NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) — Spryker, the leading composable commerce…
Pertamina’s Innovations Support Energy Transition in Indonesia
New Delhi, India, Aug 23, 2023 – (ACN Newswire) – As a state-owned energy company,…
Bio-Generative Artist Agoria Concludes Scorpios, Mykonos’ $3m Summer Art Program
LONDON, Aug 23, 2023 – (ACN Newswire) – French AI artist and polyhyphenate creative Agoria…
HFR Leads 6G Global Standardization as Co-Chair of the Open RAN Industry Alliance
SEOUL, S.KOREA, Aug 23, 2023 – (ACN Newswire) – HFR, Inc. (KOSDAQ 230240), a leading…
Pertamina explores energy cooperation in Africa, supports President’s visit
NAIROBI, Kenya, Aug 23, 2023 – (ACN Newswire) – PT Pertamina (Persero) and its sub-holdings…
Standard AI Brings New Innovative Retail Experiences to Life with Google Cloud Vertex AI
Standard AI will leverage Google Cloud’s AI tools to transform retail operations, elevate the in-store…
Twilio CustomerAI Fuels Next Generation Customer Relationships and Competitive Advantage for Businesses Worldwide
Predictions and Voice Intelligence Launches Drive Deeper, Actionable Understanding of Customers New Generative AI Tools…
CyberLink Launches FaceMe® Platform 5.4, a Complete API Solution for Facial Recognition
TAIPEI, Taiwan–(BUSINESS WIRE)–CyberLink Corp. (5203.TW), a pioneer in AI and facial recognition technologies, today announced…
Portkey.ai Secures $3m Funding Round As It Enables Any Business To Create AI Apps Faster
Portkey.ai is enabling tech teams to fast track the build and deployment of generative AI…
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
Aardvark to acquire global development and commercialization rights to ADAIR and all intellectual property outside…
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
Aardvark to acquire global development and commercialization rights to ADAIR and all intellectual property outside…
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
HAMILTON, BERMUDA, Aug. 23, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the “Company”)…
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
HAMILTON, BERMUDA, Aug. 23, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the “Company”)…
U.S. Food and Drug Administration Approves Orphan Drug Designation for NXC-201 as a Treatment for Multiple Myeloma
FDA Orphan Drug Designation (“ODD”) qualifies NXC-201 for: 7 years of U.S. market exclusivity after…
U.S. Food and Drug Administration Approves Orphan Drug Designation for NXC-201 as a Treatment for Multiple Myeloma
FDA Orphan Drug Designation (“ODD”) qualifies NXC-201 for: 7 years of U.S. market exclusivity after…
U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma
FDA Orphan Drug Designation (“ODD”) qualifies NXC-201 for: 7 years of U.S. market exclusivity after…
U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma
FDA Orphan Drug Designation (“ODD”) qualifies NXC-201 for: 7 years of U.S. market exclusivity after…
Pyxis Oncology Successfully Completes Acquisition of Apexigen
Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as…
Pyxis Oncology Successfully Completes Acquisition of Apexigen
Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as…